Related Experiment Video
Updated: May 24, 2026
14:55
Atomic Scale Structural Studies of Macromolecular Assemblies by Solid-state Nuclear Magnetic Resonance Spectroscopy
Published on: September 17, 2017
The amyloid packing difference: A pairwise comparison metric for amyloid structures.
1Medical Research Council Laboratory of Molecular Biology, CB2 0QH Cambridge, UK.
Structure (London, England : 1993)
|May 22, 2026
Summary
A new method, amyloid packing difference (APD), quantifies structural variations in amyloid proteins. This tool helps differentiate between amyloid structures linked to various neurodegenerative diseases and those specific to certain conditions.
Area of Science:
- Biochemistry
- Structural Biology
- Neuroscience
Background:
- Proteins can form diverse amyloid structures, necessitating methods to compare them.
- Understanding these structural variations is crucial for studying neurodegenerative diseases.
Purpose of the Study:
- Introduce and validate the amyloid packing difference (APD) metric.
- Assess APD's utility in comparing amyloid structures across different proteins and diseases.
Main Methods:
- Developed the amyloid packing difference (APD) metric.
- Quantified structural differences based on unique cross-β packing and side-chain orientations.
- Applied APD to analyze structures of α-synuclein, prion protein, tau, TDP-43, TAF15, antibody light chains, and transthyretin.
Main Results:
- APD successfully clustered α-synuclein folds, mirroring structural superposition results.
- Amyloid structures from different neurodegenerative diseases showed APD values >20%.
- Structures associated with the same disease had APD values <40%, while peripheral amyloidosis structures had APD >60% and transthyretin filaments had APD <25%.
Conclusions:
- APD provides a quantitative measure for comparing amyloid structures.
- APD values offer insights into structural similarities and differences relevant to disease classification.
- The APD metric aids in interpreting structural comparisons for future amyloid research.
Related Concept Videos
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...